- Previous Close
0.0083 - Open
0.0074 - Bid 0.0076 x --
- Ask 0.0100 x --
- Day's Range
0.0074 - 0.0100 - 52 Week Range
0.0020 - 0.0885 - Volume
182,750 - Avg. Volume
269,120 - Market Cap (intraday)
4.996M - Beta (5Y Monthly) --
- PE Ratio (TTM)
0.45 - EPS (TTM)
0.0220 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Delex Healthcare Group, Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines. It also engages in the development, distribution, and trading of medical supplies, equipment, pharmaceutical products, and food supplements. In addition, the company offers medical devices and machines, such as cardiovascular ultrasounds; needless connectors and IV lines; and ambulatory/PCA infusion pumps for critical care, anti-infectives, and anesthesia, as well as provides after sales services. It also sells its products through online drugstore. The company was incorporated in 2017 and is based in New York, New York.
delexpharma.com149
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BNCM
View MorePerformance Overview: BNCM
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BNCM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BNCM
View MoreValuation Measures
Market Cap
5.00M
Enterprise Value
5.00M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
10.47%
Return on Assets (ttm)
9.43%
Return on Equity (ttm)
38.21%
Revenue (ttm)
7.26M
Net Income Avi to Common (ttm)
760.41k
Diluted EPS (ttm)
0.0220
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-194.28k